Pulmonx (NASDAQ:LUNG) Given New $13.00 Price Target at Piper Sandler
Pulmonx (NASDAQ:LUNG – Free Report) had its target price cut by Piper Sandler from $17.00 to $13.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Other analysts have also recently issued research reports about the stock. Craig Hallum started coverage on shares of Pulmonx […]
More Stories
Twelve Points Wealth Management LLC Cuts Stock Holdings in Vanguard S&P 500 ETF (NYSEARCA:VOO)
Twelve Points Wealth Management LLC lowered its stake in shares of Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) by...
GameSquare Esports (OTCMKTS:GMSQF) Trading Up 22.7% – Still a Buy?
GameSquare Esports Inc. (OTCMKTS:GMSQF – Get Free Report)’s stock price was up 22.7% on Wednesday . The stock traded as...
SingularityNET (AGIX) Trading Down 2.9% Over Last Week
SingularityNET (AGIX) traded up 4.3% against the U.S. dollar during the 1-day period ending at 22:00 PM ET on October...
Singularity Future Technology (NASDAQ:SGLY) Stock Price Up 4.6% – Here’s Why
Singularity Future Technology Ltd. (NASDAQ:SGLY – Get Free Report) rose 4.6% during mid-day trading on Wednesday . The stock traded...
Multibit (MUBI) Achieves Self Reported Market Capitalization of $28.34 Million
Multibit (MUBI) traded 0.4% higher against the U.S. dollar during the 24 hour period ending at 22:00 PM E.T. on...
Cobak Token Tops 1-Day Volume of $1.06 Million (CBK)
Cobak Token (CBK) traded 0.2% lower against the US dollar during the one day period ending at 22:00 PM ET...